The 8 most recent market catalysts affecting $HSTM, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 5, 2026
Corporate Catalyst
Bullish
Impact 55
Canaccord Genuity Maintains HealthStream at Hold, Raises Price Target to $32
Canaccord Genuity reaffirmed its 'Hold' rating on HealthStream, indicating a neutral stance on the stock's near-term performance. However, the firm did raise its price target from …
Nov 4, 2026
Corporate Catalyst
Bearish
Impact 65
Craig-Hallum Downgrades HealthStream to Hold
Craig-Hallum analyst Matthew Hewitt downgraded HealthStream (HSTM) from Buy to Hold, setting a $40 price target. This downgrade is primarily due to the stock's substantial year-to-…
Nov 2, 2026
Corporate Catalyst
Bullish
Impact 75
HealthStream Increases Fiscal Year 2026 Guidance
HealthStream, Inc. announced an upward revision to its full fiscal year 2026 financial guidance for both total revenue and adjusted EBITDA. This positive adjustment stems from stro…
Nov 2, 2026
Corporate Catalyst
Bullish
Impact 75
HealthStream Announces Third Quarter 2026 Results
HealthStream announced its third-quarter 2026 financial results, showing an 8.9% increase in revenue to $83.3 million compared to the prior year. However, this top-line growth was …
Oct 13, 2026
Corporate Catalyst
Neutral
Impact 55
Freedom Capital Markets Initiates Coverage On HealthStream with Hold Rating, Announces Price Target of $36
Freedom Capital Markets, through analyst Gene Mannheimer, has begun covering HealthStream (HSTM), assigning a 'Hold' rating and a $36 price target. This is a routine event for publ…
Sep 21, 2026
Corporate Catalyst
Neutral
Impact 65
HealthStream 13D Filing Shows WJRJJ Ventures Reports 9.6% Stake In Co As Of September 14, 2026
The 13D filing reveals WJRJJ Ventures has taken a 9.6% stake in HealthStream. This is significant because a stake of this size often indicates an activist investor or a large insti…
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 75
HealthStream Raises FY2026 Sales Guidance from $323.000M-$330.000M to $327.000M-$332.000M vs $327.279M Est
HealthStream (HSTM) has updated its financial outlook for FY2026, increasing its sales guidance from a range of $323M-$330M to $327M-$332M. This upward revision indicates managemen…
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 92
HealthStream Q2 EPS $0.23 Beats $0.17 Estimate, Sales $83.732M Beat $80.827M Estimate
HealthStream's Q2 earnings of $0.23 per share significantly beat the analyst consensus of $0.17, representing a 35.29% beat and a 27.78% increase year-over-year. Sales also exceede…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.